I have been unable to confirm that an Australian TGA approval is accepted by New Zealand via a Mutual Recognition Agreement - I ran across this somewhere, but cannot find a definitive source. So here I am on the Cove!

Does anyone know the answer? Thanks!
The Mutual Recognition Agreement (MRA) on standards and conformity assessment between Australia and the European Community (EC) was signed in Canberra on 24 June 1998 and came into effect on 1 January 1999. The MRA covers eight industry sectors of which the Therapeutic Goods Administration (TGA) has responsibility for two; medicinal products GMP inspection and batch certification, and medical devices conformity assessment.
The EC-MRA applies to medical devices manufactured in the European Community, Australia and New Zealand.
It is defined in the
AGREEMENT ON MUTUAL RECOGNITION IN RELATION TO CONFORMITY ASSESSMENT, CERTIFICATES AND MARKINGS BETWEEN THE EUROPEAN COMMUNITY AND AUSTRALIA
The detailed scope is mentioned in the
TGA News -
The agreement applies to therapeutic goods manufactured in Australia, New Zealand and the European Community (Belgium, Denmark, Germany, Greece, Spain, France, Ireland, Italy, Luxembourg, the Netherlands, Austria, Portugal, Finland, Sweden and the United Kingdom).
The agreement does not cover products exported to or imported from Norway, Iceland, Liechtenstein and Switzerland. These countries belong to the European Free Trade Association (EFTA). However, Australia is negotiating an MRA with these countries. When this is finalised, the MRA will cover all countries included in the European Economic Area (EEA).